Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
2,921,778
Share change
-1,495,829
Total reported value
$2,436,675
Put/Call ratio
106%
Price per share
$0.83
Number of holders
24
Value change
-$1,654,962
Number of buys
8
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2021

As of 31 Dec 2021, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,921,778 shares. The largest 10 holders included MORGAN STANLEY, GROUP ONE TRADING, L.P., Phoenix Holdings Ltd., Spire Wealth Management, BlackRock Inc., TWO SIGMA ADVISERS, LP, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.